# Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation

> **NCT00018148** · PHASE2 · COMPLETED · sponsor: **US Department of Veterans Affairs** · enrollment: 158 (actual)

## Conditions studied

- Smoking

## Interventions

- **DRUG:** nortriptyline
- **DRUG:** transdermal nicotine

## Key facts

- **NCT ID:** NCT00018148
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-04
- **Primary completion:** 2002-12
- **Final completion:** 2003-01
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2010-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00018148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00018148, "Combined Nortriptyline and Transdermal Nicotine for Smoking Cessation". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00018148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*